No abstract available
MeSH terms
-
Absorptiometry, Photon
-
Adult
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Alendronate / administration & dosage
-
Alendronate / therapeutic use
-
Body Mass Index
-
Bone Density
-
Bone Density Conservation Agents / administration & dosage
-
Bone Density Conservation Agents / therapeutic use*
-
Bone Diseases, Metabolic / diagnosis
-
Bone Diseases, Metabolic / therapy
-
Female
-
Femoral Fractures / etiology
-
Femoral Fractures / prevention & control
-
Follow-Up Studies
-
Fractures, Bone / etiology
-
Fractures, Bone / prevention & control
-
Humans
-
Middle Aged
-
Organometallic Compounds / administration & dosage
-
Organometallic Compounds / therapeutic use
-
Osteoporosis, Postmenopausal / complications
-
Osteoporosis, Postmenopausal / diagnosis
-
Osteoporosis, Postmenopausal / drug therapy*
-
Osteoporosis, Postmenopausal / prevention & control
-
Practice Guidelines as Topic
-
Raloxifene Hydrochloride / administration & dosage
-
Raloxifene Hydrochloride / therapeutic use
-
Risk Factors
-
Spinal Fractures / etiology
-
Spinal Fractures / prevention & control
-
Tablets
-
Teriparatide / administration & dosage
-
Teriparatide / therapeutic use
-
Thiophenes / administration & dosage
-
Thiophenes / therapeutic use
-
Time Factors
Substances
-
Bone Density Conservation Agents
-
Organometallic Compounds
-
Tablets
-
Thiophenes
-
strontium ranelate
-
Teriparatide
-
Raloxifene Hydrochloride
-
Alendronate